• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES MITRIS RESILIA MITRAL VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES MITRIS RESILIA MITRAL VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11400M29
Medical Device Problem Codes Fluid/Blood Leak (1250); Intravalvular regurgitation (4068)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 01/16/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a patient with a 29mm 11400m mitris valve was placed under evaluation for valve-in-valve intervention after an implant duration of one (1) year, eight (8) months due to mitral regurgitation.
 
Additional Manufacturer Narrative
H11: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Additional Manufacturer Narrative
H11: additional manufacturer narrative: updated: b4, d4, g3, g6, h2, h4, h6.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Regurgitation identified post-procedurally has many potential root causes, including structural valve deterioration (svd), non-structural valve dysfunction (nsvd), endocarditis and/or thrombosis.Regurgitation occurring during device implantation or post-procedurally is most commonly related to patient and/or procedural factors and is not typically an indication of a device malfunction related to a manufacturing non-conformance.There is no evidence to suggest a manufacturing defect caused or contributed to the reported event.A definitive root cause is unable to be determined, however, patient and likely caused or contributed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRIS RESILIA MITRAL VALVE
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2 - office m2013
irvine, CA 92614
9492506615
MDR Report Key21351423
Report Number2015691-2025-00916
Device Sequence Number7835377
Product Code LWR
UDI-Device Identifier00690103205558
UDI-Public(01)00690103205558(17)250315(11)230316
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P150048
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date03/15/2025
Device Model Number11400M29
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/16/2025
Supplement Date Received by Manufacturer03/14/2025
Initial Report FDA Received Date02/10/2025
Supplement Report FDA Received Date03/19/2025
Date Device Manufactured03/16/2023
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention; Hospitalization;
Patient Age70 YR
Patient SexFemale
-
-